Related Experiment Video

Updated: Aug 29, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
10:13

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples

Published on: December 2, 2022

Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons

Nicolas J Rahier1, Brian M Eisenhauer, Rong Gao

  • 1Department of Chemistry, University of Virginia, Charlottesville, Virginia 22901, USA.

Organic Letters
|January 30, 2004
PubMed

Insights

Researchers developed four new camptothecin analogues to enhance water solubility. These compounds are stable, soluble, and effectively inhibit topoisomerase I, showing promise for cancer therapy research.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • Camptothecin is a potent anticancer agent with poor water solubility.
  • Improving solubility is crucial for developing effective camptothecin-based therapeutics.
  • Topoisomerase I is a key target in cancer chemotherapy.

Purpose of the Study:

  • To synthesize novel camptothecin analogues with improved water solubility.
  • To evaluate the stability and biological activity of these new compounds.
  • To assess their interaction with human topoisomerase I-DNA complex.

Main Methods:

  • Chemical synthesis of four 20-O-phosphate and phosphonate camptothecin analogues.
  • Assessment of water solubility and stability at physiological pH.
  • Evaluation of stabilization of the human topoisomerase I-DNA covalent binary complex.
  • Enzyme-dependent growth inhibition assays in yeast expressing human topoisomerase I.

Main Results:

  • Four novel camptothecin analogues were successfully prepared.
  • These analogues exhibited high water solubility and stability at physiological pH.
  • The compounds demonstrated sequence selectivity in stabilizing the topoisomerase I-DNA complex, similar to camptothecin.
  • All four analogues inhibited yeast growth in an enzyme-dependent manner.

Conclusions:

  • The synthesized camptothecin analogues offer improved physicochemical properties.
  • These analogues retain the biological activity and target engagement of camptothecin.
  • The findings support the potential of these analogues as therapeutic agents for targeting topoisomerase I.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...